BioGlobal Accelerator Program

The BioGlobal Accelerator Program is a highly competitive, 6-week (in-person) collaborative accelerator that helps bioscience companies scale with velocity. The BioGlobal Accelerator Program is the first and only one of its kind in San Antonio specialized for early-stage companies focusing on medical devices, biotech, and healthcare IT.

Through coaching by Entrepreneurs In Residence (EIR), mentoring from industry experts, and interactive technical and business sessions, this unique program provides the resources entrepreneurs need to succeed. VelocityTX connects high-potential companies with custom growth strategies, talent, investors, and a prominent bioscience ecosystem.

Early-stage companies have two options for payment terms (please refer to program agreement for details) and dedicated co-working space at VelocityTX Innovation Center.

Application Opens: April 4, 2022
Application Closes: May 25, 2022
Cohort Announced: August 2022
Program Duration: Sept. 12 – Oct. 21, 2022

Program Benefits

Entrepreneurs in Residence (EIRs)


Pitch Coaching

Demo Day

Networking Events

Innovation Center

Entrepreneurs in Residence (EIRs)


Pitch Coaching

Demo Day

Networking Events

Innovation Center

Program Curriculum

Technical Modules Business Modules
Unmet Clinical Need and Market
Business Models
Health IT and Data
Legal ad Insurance
Clinical Trials and FDA Regulations
Tax Implications
HIPAA Compliance
Finance and Accounting
Reimbursement and Financial Considerations
HR Practices
R&D and Product Development
Funding Approaches
Hospital Procurement and Sales Strategy
Organizational Development
Manufacturing Strategy and Outsourcing
Building a Pitch

Requirements and Eligibility

Program Expectations

Program Agreement

VelocityTX offers companies two options for payment terms. Please review the program and SAFE agreements to determine which payment option is right for your company’s financing situation.

Application Process

The application opens on April 4, 2022, with a closing date of May 25, 2022. Only eight companies will be accepted into the program. The cohort selection will be announced in August 2022.

Meet the 2021 BioGlobal Accelerator Cohort

Alt-Bionics | Texas |

A medical device company that aims to tackle the problem of high-cost prosthetics by delivering affordable alternatives to the prosthetic market. Alt-Bionics is applying new, advanced, and low-cost technology to medical devices to display the capabilities that are similar in both form and function to higher-priced devices.  

Bioxiplas | Chile |

Manufactures and commercializes biodegradable personal disposable equipment, compostable and biodegradable plastic bags, and a new patented line of anti-viral (SARS COV2) material. 

Eisana | Texas |

An oncology solution company providing products to solve the unmet needs resulting from cancer treatment. While cancer survival continues to improve, side effects remain significant in terms of reduced quality of life and healthcare cost.

Neurognos | Chile |

Is developing a noninvasive and simple disease diagnostic strategy for early Alzheimer’s screening, utilizing cutting-edge miRNA and Machine Learning technology. 

Olifant Medical Inc. | Texas

Is developing and commercializing novel medical device solutions for healthcare workers’ technical challenges, creating better patient-provider experiences, leading to better outcomes for patients, and saving lives. 

Thummi | Brazil |

Is an application that records and organizes the patient’s day-to-day events and provides real-time reports to clinics and doctors, to improve patient quality of life. 

2021 International Partner

VelocityTX has partnered with one Latin America incubator that accelerates companies in their home country before being sent to San Antonio for the BioGlobal Accelerator Program.

Thank you to our Sponsors

for generously supporting VelocityTX and future innovators.

Incubator Program

The Incubator Program is designed to scale early-stage bioscience companies by providing long-term support and includes office and meeting space, access to industry experts, mentors, and more.

CEO Roundtable

The CEO Roundtable is an exclusive membership program that brings together executives from non-competing bioscience and healthcare companies to foster innovation, collaboration, and connections.